Wei Cao
Chief Executive Officer at GRACELL BIOTECHNOLOGIES INC.
Wei Cao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Chief Executive Officer | 30/04/2017 | - |
| Chairman | 30/04/2017 | - | |
| Founder | 30/04/2017 | - | |
Gracell Biotechnologies (Shanghai) Co., Ltd.
 Gracell Biotechnologies (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China. The Chinese company discovers and develops cellular therapeutics for patients suffering from cancer. The company was founded in 2017 by Wei Cao, who has been the CEO since 2017. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | 20/05/2017 | - | |
| Gracell Biotechnologies (HK) Ltd. | Chief Executive Officer | - | - |
| Gracell Biopharmaceuticals, Inc. | Chief Executive Officer | - | - |
Suzhou Gracell Biotechnologies Co., Ltd.
 Suzhou Gracell Biotechnologies Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Suzhou Gracell Biotechnologies Co., Ltd. is a company that manufactures cancer cellular medicines. The company is based in Suzhou, China. The CEO of the Chinese company is Wei Cao. | Chief Executive Officer | - | - |
Career history of Wei Cao
Former positions of Wei Cao
| Companies | Position | Start | End |
|---|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Director/Board Member | 05/02/2013 | 30/04/2016 |
| Chief Executive Officer | 29/09/2013 | 05/02/2016 | |
| Chief Operating Officer | 05/02/2013 | 28/09/2013 | |
| President | 05/02/2013 | 28/09/2013 | |
| Cellular Biomedicine Group Ltd. | Director/Board Member | 31/07/2010 | 31/01/2013 |
| Chief Operating Officer | 31/07/2010 | 31/01/2013 | |
| President | 31/07/2010 | 31/01/2013 |
Training of Wei Cao
| Medical College of Virginia | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
| Zhongshan Hospital Fudan University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| China | 5 |
| Hong Kong | 2 |
Operational
| Chief Executive Officer | 6 |
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
| Cellular Biomedicine Group Ltd. | |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
Gracell Biotechnologies (Shanghai) Co., Ltd.
Gracell Biotechnologies (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China. The Chinese company discovers and develops cellular therapeutics for patients suffering from cancer. The company was founded in 2017 by Wei Cao, who has been the CEO since 2017. | Health Technology |
| Gracell Biotechnologies (HK) Ltd. | |
| Gracell Biopharmaceuticals, Inc. | |
Suzhou Gracell Biotechnologies Co., Ltd.
Suzhou Gracell Biotechnologies Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Suzhou Gracell Biotechnologies Co., Ltd. is a company that manufactures cancer cellular medicines. The company is based in Suzhou, China. The CEO of the Chinese company is Wei Cao. | Health Technology |
- Stock Market
- Insiders
- Wei Cao
- Experience
